Administering Shingrix previously required combining a lyophilised antigen with a liquid adjuvant from two separate vials.

GSK shares fell after a Food and Drug Administration advisory committee voted against approval of the company's Blenrep drug, a setback for its bid to reintroduce the blood-cancer treatment in the U.S ...

The panel expressed concerns about the proposed doses of Blenrep (belantamab mafodotin) in GSK's marketing application, ...

FDA advisers on Thursday voted against GSK's blood cancer drug Blenrep, finding that its risks outweighed its benefits at the ...

Another week where the market has traded in a narrow range comes to an end today. The Nifty, so far, is down 38 points for ...

By Sanchayaita Roy (Reuters) -European shares rose on Friday, boosted by gains in Vestas and Saab, while investors focused on ...